NL-OMON38577已完成不适用
Pharmacokinetics and Pharmacodynamics of metformin in patients with type 2 diabetes and renal impairment - Metformin in diabetic nephropathy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >= 18 years
- •Patients prescribed metformin for at least 2 days
- •eGFR > 15 ml/min/1.73m2
- •Willing to provide informed consent
排除标准
- •Need for chronic hemodialysis
- •Presence of severe debilitating illness at the discretion of the treating physician
- •Donation of blood to the blood bank in prior 3 months
- •Veins not suitable for venepuncture
研究者
相似试验
进行中（未招募）
1 期
Research of biological mechanisms of antidiabetic drug metformin in context of human organism and microorganisms living in gutEUCTR2016-001092-74-LVatvian Biomedical Research and Study centre
已完成
不适用
A study of factors affecting the concentrations of metformin in type 2 diabetic patientsType 2 diabetesMetabolic and Endocrine - DiabetesACTRN12611000908932Prof Richard Day120
招募中
4 期
Can metformin be safely used in patients with heart failure?Cardiovascular - Other cardiovascular diseasesChronic heart failureACTRN12617001418369St Vincent's Hospital Sydney50
已完成
4 期
The safety and disposition of metformin in people with liver diseaseChronic liver diseaseMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12619001292167St Vincent's Hospital, Sydney24
已完成
不适用
The safety and disposition of metformin in people with liver disease and diabetes already treated with metformiChronic liver diseaseMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonDiabetesACTRN12619001348145St Vincent's Hospital, Sydney34